Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| New England Journal of Medicine Publishes Case Reports on the Investigational Use of Soliris® (eculizumab) in Patients ... (Business Wire via Yahoo! Finance) |
 |
 |
|
CHESHIRE, Conn.----Two separate case reports published today in the New England Journal of Medicine examine the investigational use of Soliris ® , a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. , in patients with a rare and severe inflammatory disease called atypical Hemolytic Uremic Syndrome . |
